BG61242B2 - Твърд фармацевтичен състав за орална употреба набаза дапипразол - Google Patents

Твърд фармацевтичен състав за орална употреба набаза дапипразол Download PDF

Info

Publication number
BG61242B2
BG61242B2 BG98588A BG9858894A BG61242B2 BG 61242 B2 BG61242 B2 BG 61242B2 BG 98588 A BG98588 A BG 98588A BG 9858894 A BG9858894 A BG 9858894A BG 61242 B2 BG61242 B2 BG 61242B2
Authority
BG
Bulgaria
Prior art keywords
dapiprazole
acid addition
addition salt
magnesium oxide
pharmaceutical composition
Prior art date
Application number
BG98588A
Other languages
Bulgarian (bg)
English (en)
Inventor
Depalmo Angeli
Leandro Baiocchi
Original Assignee
Angelini Ricerche S.P.A. Societa'consortile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche S.P.A. Societa'consortile filed Critical Angelini Ricerche S.P.A. Societa'consortile
Publication of BG61242B2 publication Critical patent/BG61242B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG98588A 1991-07-24 1994-02-25 Твърд фармацевтичен състав за орална употреба набаза дапипразол BG61242B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Publications (1)

Publication Number Publication Date
BG61242B2 true BG61242B2 (bg) 1997-03-31

Family

ID=11360418

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98588A BG61242B2 (bg) 1991-07-24 1994-02-25 Твърд фармацевтичен състав за орална употреба набаза дапипразол

Country Status (9)

Country Link
US (1) US5234927A (de)
EP (1) EP0524696B1 (de)
JP (1) JP3330977B2 (de)
AT (1) ATE136778T1 (de)
BG (1) BG61242B2 (de)
CA (1) CA2074580C (de)
DE (1) DE69209916T2 (de)
DK (1) DK0524696T3 (de)
IT (1) IT1250701B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
PT1421944E (pt) 2001-08-27 2008-01-03 Kyowa Chem Ind Co Ltd Comprimidos antiácidos e laxantes que compreendem óxido demagnésio
WO2008033024A2 (en) * 2006-09-15 2008-03-20 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
AU2007295178B2 (en) * 2006-09-15 2013-04-18 Echo Pharmaceuticals B.V. Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
IT1094076B (it) * 1978-04-18 1985-07-26 Acraf Cicloalchiltriazoli
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4879294A (en) * 1988-01-28 1989-11-07 Angelini Pharmaceuticals Ltd. Opthalmic composition
IT1224250B (it) * 1988-06-10 1990-09-26 Acraf Associzione del depiprazolo con la morfina

Also Published As

Publication number Publication date
CA2074580A1 (en) 1993-01-25
IT1250701B (it) 1995-04-21
ATE136778T1 (de) 1996-05-15
US5234927A (en) 1993-08-10
ITMI912044A1 (it) 1993-01-25
DE69209916T2 (de) 1996-12-05
CA2074580C (en) 2002-12-10
JPH05194228A (ja) 1993-08-03
EP0524696B1 (de) 1996-04-17
DK0524696T3 (da) 1996-08-12
ITMI912044A0 (it) 1991-07-24
JP3330977B2 (ja) 2002-10-07
DE69209916D1 (de) 1996-05-23
EP0524696A1 (de) 1993-01-27

Similar Documents

Publication Publication Date Title
EP3417861B1 (de) Pharmazeutische zusammensetzung mit jak-kinaseinhibitor oder pharmazeutisch unbedenklichem salz davon
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
PL204866B1 (pl) Kompozycje farmaceutyczne
KR20010062478A (ko) 경구투여후 트리메트아지딘의 지속적 방출을 가능케 하는매트릭스 정제
BG61242B2 (bg) Твърд фармацевтичен състав за орална употреба набаза дапипразол
RU2199318C2 (ru) Стабилизированные в отношении рацемизации фармацевтические лекарственные формы силанзетрона
US4428951A (en) Long acting pharmaceutical composition
EP0310999B1 (de) Pharmazeutische Zusammensetzung, enthaltend Piperidinalkanolderivate
US5520928A (en) Pharmaceutical composition of ticlopidine hydrochloride
US5872128A (en) Stabilized composition of ticlopidine hydrochloride
US5785995A (en) Pharmaceutical tablet of amiodarone salt
JP2022007461A (ja) トルバプタン含有口腔内崩壊錠
JPH11349479A (ja) 安定なマレイン酸エナラプリル錠剤
EP1818050A1 (de) Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
BG63488B1 (bg) Таблети с високо съдържание на фамцикловир
JP7355846B2 (ja) 固形製剤
JP6638947B1 (ja) 保存安定性に優れたレボセチリジン医薬組成物
JP2018184382A (ja) エゼチミブ含有錠剤およびその製法
CN111683659B (zh) 一种氨基吡喃衍生物的组合物
CA1060344A (en) Antihypertonic agent
JP6455293B2 (ja) セルトラリン及び／又はその薬学上許容しうる塩を含む製剤
EP0519371A1 (de) Feste, stabilisierte Arzneimittelform von Choline-Metall-Carboxymethylzellulose-Salicylat enthaltenden Zusammensetzungen
EP4027980A1 (de) Pharmazeutische formulierungen von indoleamin-2,3-dioxygenase-inhibitoren
JP2004043509A (ja) プラバスタチンナトリウム錠の貯蔵安定化方法